The 2023 contribution limit for Healthcare Flexible Spending Accounts (FSAs) is increasing to $3,050, an increase of $200 from 2022. The maximum carryover amount that employers may implement also increases to $610 (20% of the contribution limit).

The IRS has reminded taxpayers that the cost of home testing for COVID-19 is an eligible medical expense that can be paid or reimbursed under health flexible spending arrangements (health FSAs), health savings accounts (HSAs), and some health reimbursement arrangements (HRAs). The cost to diagnose COVID-19 is an eligible medical expense for tax purposes.

In addition, the costs of personal protective equipment, such as masks, hand sanitizer and sanitizing wipes, for the primary purpose of preventing the spread of COVID-19 are eligible medical expenses.